Bloomberg the Company & Products

Bloomberg Anywhere Login


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

Last SFr.45.70 CHF
Change Today 0.00 / 0.00%
Volume 0.0
ABT On Other Exchanges
New York
SIX Swiss Ex
Sao Paulo
As of 12:43 PM 03/27/15 All times are local (Market data is delayed by at least 15 minutes).

abbott laboratories (ABT) Snapshot

Previous Close
Day High
Day Low
52 Week High
03/19/15 - SFr.46.85
52 Week Low
04/2/14 - SFr.33.98
Market Cap
Average Volume 10 Days
Shares Outstanding
Dividend Yield
Current Stock Chart for ABBOTT LABORATORIES (ABT)

abbott laboratories (ABT) Details

Abbott Laboratories manufactures and sells health care products worldwide. Its Established Pharmaceutical Products segment offers branded generic pharmaceuticals for the treatment of pancreatic exocrine insufficiency; irritable bowel syndrome; intrahepatic cholestasis or depressive symptoms; gynecological disorders; dyslipidemia; hypertension; hypothyroidism; pain, fever, and inflammation; hormone replacement therapy; anti-infective and influenza vaccines; and product that regulates physiological rhythm of the colon. The company’s Diagnostic Products segment provides diagnostic systems and tests, such as immunoassay and clinical chemistry systems; assays for screening and diagnosis for drugs of abuse, cancer, therapeutic drug monitoring, fertility, and physiological and infectious diseases; hematology systems and reagents; genomic-based tests; informatics and automation solutions; and diagnostic systems and tests for blood analysis, as well as instruments that automate the extraction, purification, and preparation of DNA and RNA from patient samples, and detects and measures infectious agents. Its Nutritional Products segment offers pediatric and adult nutritional products, such as prepared infant and follow-on formula. The company’s Vascular Products segment provides coronary, endovascular, vessel closure, and structural heart devices to treat vascular diseases. Abbott Laboratories also offers blood, continuous, and flash glucose monitoring systems, including test strips, sensors, data management decision software, and accessories for people with diabetes under the FreeStyle brand; and medical devices for the eye, including cataract surgery, LASIK surgery, contact lens care products, and dry eye products. The company serves retailers, wholesalers, hospitals, health care facilities, laboratories, physicians’ offices, and government agencies. It has strategic alliance with Fonterra. The company was founded in 1888 and is headquartered in Abbott Park, Illinois.

77,000 Employees
Last Reported Date: 02/27/15
Founded in 1888

abbott laboratories (ABT) Top Compensated Officers

Chairman, Chief Executive Officer and Chairma...
Total Annual Compensation: $2.0M
Chief Financial Officer and Executive Vice Pr...
Total Annual Compensation: $1.0M
Executive Vice President of Nutritional Produ...
Total Annual Compensation: $743.3K
Executive Vice President of Medical Devices
Total Annual Compensation: $696.8K
Executive Vice President of Diagnostic Produc...
Total Annual Compensation: $690.0K
Compensation as of Fiscal Year 2014.

abbott laboratories (ABT) Key Developments

Kentucky Sues Purdue Pharma over Addictions

Kentucky is suing Purdue Pharma on claims that the company misrepresented its prescription painkiller, resulting in a wave of addiction and increased medical costs across the state. But before the trial can start, both sides must file "admissions so the court could determine a set of facts that are not in dispute. Kentucky officials filed theirs, which included claims that Purdue Pharma lied about the addictiveness of the drug to doctors, who then overprescribed it to an unwitting population of poor people in eastern Kentucky. But when Purdue Pharma did not respond, the judge ruled those claims were admissible in court. That cleared the way for the state to win the lawsuit with the only question being how much Purdue Pharma would have to pay. The judge's decision surprised company officials. When the state filed its claims back in 2007, Purdue Pharma had 45 days to respond. But in the middle of that window, the case was transferred to federal court at the company's request. Both sides had to file new sets of paperwork, and the original deadline for the state case disappeared. They pointed out a co-defendant in the case, Abbott Labs, also missed the deadline yet the court allowed that company to file a response anyway. And they said if the case moves forward like this, the company won't be able to defend itself and won't be able to get information from Kentucky officials about the state's role in the epidemic of prescription painkiller abuse.

Abbott Laboratories to Distribute an Unchanged Quarterly Dividend on May 15, 2015

Abbott Laboratories announced that it will distribute an unchanged quarterly dividend of $0.24 per share on May 15, 2015 to holders of record on April 15, 2015 with an ex-dividend date of April 13, 2015.

Abbott Laboratories Presents at Cowen and Company 35th Annual Healthcare Conference, Mar-03-2015 10:00 AM

Abbott Laboratories Presents at Cowen and Company 35th Annual Healthcare Conference, Mar-03-2015 10:00 AM. Venue: The Boston Marriott Copley Place, Boston, Massachusetts, United States. Speakers: Brian Yoor, vice president, investor relations, Scott White, senior vice president, international nutrition.


Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
ABT:SW SFr.45.70 CHF 0.00

ABT Competitors

Market data is delayed at least 15 minutes.

Company Last Change
AbbVie Inc $57.65 USD +0.38
Danaher Corp $84.85 USD +0.53
Danone SA €62.92 EUR +0.69
General Mills Inc $54.99 USD +1.05
Thermo Fisher Scientific Inc $133.69 USD +0.62
View Industry Companies

Industry Analysis


Industry Average

Valuation ABT Industry Range
Price/Earnings 41.8x
Price/Sales 3.5x
Price/Book 3.3x
Price/Cash Flow 24.9x
TEV/Sales 2.9x

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact ABBOTT LABORATORIES, please visit Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at